| Carolyn Hasek, MA, LPC | |
|
1126 S 70th St Ste 112-113, West Allis, WI 53214 | |
| (414) 727-2789 | |
| Not Available |
| Full Name | Carolyn Hasek |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 1126 S 70th St Ste 112-113, West Allis, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700176815 | NPI | - | NPPES |
| 1700176815 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Secondary |
| 101YP2500X | Counselor - Professional | 6983-125 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carolyn Hasek, MA, LPC 15935 Luella Dr, Brookfield, WI 53005-3504 Ph: (414) 217-0952 | Carolyn Hasek, MA, LPC 1126 S 70th St Ste 112-113, West Allis, WI 53214 Ph: (414) 727-2789 |
News Archive
Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that primary and secondary endpoints were not met in Novelos' pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) with its lead product, NOV-002, in combination with first-line chemotherapy.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that its New Drug Application (NDA) submitted on December 2, 2009 to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, has received an FDA PDUFA date of October 3, 2010. This NDA review is in support of US marketing approval and registration of Dyloject for the management of acute moderate-to-severe pain in adults.
In the era of launching Kickstarter campaigns to pay for just about anything, Carnegie Mellon University ethicists warn that the trend of patients funding their own clinical trials may do more harm than good.
Going from an occasional user of marijuana to a weekly or daily user increases an adolescent's risk of having recurrent psychotic-like experiences by 159%, according to a new Canadian study published today in the Journal of Child Psychology and Psychiatry.
› Verified 5 days ago
Nicholas Paul Hayon, Counselor Medicare: Not Enrolled in Medicare Practice Location: 10201 W Lincoln Ave, Suite 102, West Allis, WI 53227 Phone: 414-546-6880 Fax: 414-546-6891 | |
Lashawna Thomas, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2814 S 108th St, West Allis, WI 53227 Phone: 414-885-3525 Fax: 262-643-4617 | |
Ashley A Mitchell, SAC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 2814 S 108th St, West Allis, WI 53227 Phone: 414-885-3525 | |
Charity Walsh, LPC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1205 S 70th St, Ste 301, West Allis, WI 53214 Phone: 414-475-2788 | |
Mr. Christian Lamarr Lemmie, LPC, SAC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 2424 S 102nd St, West Allis, WI 53227 Phone: 414-203-4514 | |
Nicole F Jensen, LPC Counselor Medicare: Medicare Enrolled Practice Location: 2424 S 90th St, West Allis, WI 53227 Phone: 414-773-4312 Fax: 414-329-5637 | |
Grace Ellul, Counselor Medicare: Not Enrolled in Medicare Practice Location: 10150 W National Ave Ste 390, West Allis, WI 53227 Phone: 414-545-4430 |